3
Views
0
CrossRef citations to date
0
Altmetric
Abstracts

Literature Alerts

Pages 229-247 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Blood flow in rabbit osteotomies studied with radioactive microspheres. AALTO, K., and SLATIS, P., Acta Orthopaedica Scandinavica, 1984, 55, (6), 637–639.
  • Effects of oxygen on ascorbic acid-induced lipid peroxidation in liposomal membrane. AGARWAL, S., BANERJEE, S., and CHATTERJEE, S. N., Indian Journal of Biochemistry and Biophysics, 1984, 21, (6), 357–360.
  • Effects of oxygen on ferrous sulfate induced lipid peroxidation in liposomal membrane. AGARWAL, S., BANERJEE, S., and CHATTERJEE, S. N., Indian Journal of Biochemistry and Biophysics, 1985, 22, (6), 331–334.
  • The thermodynamics of partitioning of phenothiazines between phosphate buffer and the lipid phases of cyclohexane, n-octonal and DMPC liposomes. AHMED, A. M. S., FARAH, F. H., and KELLAWAY, I. W., Pharmaceutical Research, 1985, (3), 119–124.
  • The interaction of Sendai virus glycoprotein-bearing recombinant vesicles with cell surfaces. AL AHDAL, M. N., ABIDI, T. F., and FLANAGAN, T. D., Biochimica et Biophysica Acta, 1986, 854, (2), 157–168.
  • Liver pathology accompanying chronic liposome administration in mouse. ALLEN, T. M., and SMUCKLER, E. A., Research Communications in Pathology and Pharmacology, 1985, 50, (2), 281–290.
  • Paradoxical effect of oligomycin on calcium-dependent rubidium-86 transport in human red cell ghosts. ALVAREZ, J., GARCIA SANCHO, J., and HERREROS, B., Meeting of the Physiological Society and the Societa Italiana di Fisiologia (Italian Physiological Society), Oxford Meeting, July 11–13. 1985. Journal of Physiology, 1985, 369, 113P.
  • The interaction of Sendai virus with negatively charged liposomes: Virus-induced lysis of carboxyfluorescein-loaded small unilamellar vesicles. AMSELEM, S., LOYTER, A., LICHTENBERG, D., and BARENHOLZ, Y., Biochimica et Biophysica Acta, 1985, 820, (1), 1–10.
  • Does infarct size influence loss of embolised 15-micrometer microspheres from ischaemic myocardium? ANDERSEN, K. S., VIK MO, H., and STANGELAND, L., Scandinavian Journal of Clinical Laboratory Investigation, 1986, 46, (1), 71–79.
  • Concentration of viruses from water using pig erythrocyte ghost cells. ARMON, R., KOTT, Y., and NEEMAN, Y., Water Science and Technology, 1985, 17, (10), 71–80.
  • Biodegradable microspheres II: Immune response to a heterologous and an autologous protein entrapped in polyacryl starch microparticles. ARTURSSON, P., EDMAN, P., and SJoHoLm, I., Journal of Pharmacology and Experimental Therapeutics, 1985, 234, (1), 255–260.
  • Lysozyme-induced fusion of liposomes with erythrocyte ghosts at acidic pH. ARVINTE, T., HILDEBRAND, K., WAHL, P., and NICOLAU, C., Proceedings of the National Academy of Sciences, U.S.A., 1986, 83, (4), 962–966.
  • Development of liposome production technique by countercurrent flow dialysis. ASANGER, M., and WEDER, H. G., Acta Pharmaceutica Technologica, 1985, 31, (4), 215–223.
  • Interactions between aldehyde dehydrogenase of Acinetobacter cakoaceticus with mem-brane lipids. II. Reconstitution in artificial membrane vesicles. AURICH, H., BERGMANN, R., LASCH, J., KOELSCH, R., and SORGER, H., Journal of Basic Microbiology, 1985, 25, (10), 631–636.
  • The preparation and properties of niosomes-non-ionic surfactant vesicles. BAILLIE, A. J., FLORENCE, A. T., HUME, L. R., MUIRHEAD, G. T., and ROGERSON, A., Journal of Pharmacy and Pharmacology, 1985, 37, (12), 863–868.
  • Presentation of an MuLV-related tumour antigen in liposomes as a potent tertiary immunogen after adoptive transfer. BAKOUCHE, O., and GERLIER, D., Immunology, 1986, 57, (2), 219–223.
  • Butibufen enteric-coated vs non-enteric-coated microcapsules: pharmacokinetics and gastro-intestinal blood loss effect relationships in healthy volunteers. BARRIGON, S., ESTEBAN, M., GALLARDO, J., and DEL OLMO, J., Archivos de Farmacologia y Toxicologia, 1985, 11, (3), 189–197.
  • Use of temperature-sensitive liposomes in the selective delivery of methotrexate and cis-platinum analogues to murine bladder tumor. BASSETT, J. B., ANDERSON, R. U., and TACKER, J. R., Journal of Urology, 1986, 135, (3), 612–615.
  • Penetration of a cardiotoxin into cardiolipin model membranes and its implications on lipid organization. BATENBURG, A. M., BOUGIS, P. E., ROCHAT, H., VERKLEIJ, A. J., and DE KRUIJET, B., Biochemistry, 1985, 24, (25), 7107–7110.
  • Modulation of Ca2+-mediated li+-gating of erythrocyte ghosts by external Ca-EGTA. BENJAMIN, A. M., and QUASTEL, D. M. J., Journal of Cellular Physiology, 1984, 121, (3), 508–516.
  • Activity of pentamidine-containing human red cell ghosts against visceral leishmaniasis in the hamster. BERMAN, J. D., GALLALEE, J. V., WILLIAMS, J. S., and HOCKMEYER, W. D., American Journal of Tropical Medicine and Hygiene, 1986, 35, (2), 297–302.
  • The effect of cholesterol on glycerophosphono- and glycerophosphinocholines. Permeability measurements in lipid vesicles. BITTMAN, R., CLEJAN, S., FUGLER, L., and ROSENTHAL, A. F., Biochimica et Biophysica Acta, 1986, 855, (2), 265–270.
  • Effect of cobalt(II) on spontaneous generation of free radicals in erythrocyte membranes and phospholipid liposomes. BOCHEV, P., and RIBAROV, S., Doklady Bolgarskoi Akademii Nauk, 1985, 38, (10), 1375–1377.
  • Homogeneous, liposome-based assay for total complement activity in serum. BOWDEN, D. W., RISING, M., AKOTS, G., MYLES, A., and BROEZE, R. J., Clinical Chemistry, 1986, 32,(2), 275–278.
  • Microelectrophoretic behavior of microcapsules. BURGESS, D., and CARLESS, J. E., 122nd British Pharmaceutical Conference, Leeds, England, Sept. 9–12. 1985. Journal of Pharmacy and Pharmacology, 1985, 37, (Suppl.), 15P.
  • Sulfadiazine: microencapsulation and release studies. CAMERON, R., COPPI, G., FORNI, F., IANNUCCELLI, V., and BERNABEI, M. T., Bollettino Chimko Farmaceutico, 1985, 124, (9), 393–400.
  • The role of molecular conformation in ion capture by carboxylic ionophores: a circular dichroisrn study of narasin A in single-phase solvents and liposomes. CAUGHEY, B., PAINTER, G. R., DRAKE, A. F., and GIBBONS, W. A., Biochimica et Biophysica Acta, 1986, 854, (1), 109–116.
  • Biomedical applications of artificial cells containing immobilized enzymes, proteins, cells and other biologically active materials. CHANG, T. M. S., Biotechnology Series, 1985, 5 (Enzymes Immobilized Cells Biotechnol.), 263–281.
  • Arterial embolization with various polymer materials. CHISSOV, V. I., RUSAKOV, I. G., AKIMOVA, A. IA., SOLODOVNIK, V. D., and SOLODKAIA, T. I., Khirurgiia (Moscow), 1986, (1), 73–77.
  • Studies on a new technique of microencapsulation Part II. CHOWDARY, K.R., and l(Ao, G. N., Indian Drugs, 1985, 23, (1), 58.
  • Redistribution of arterial blood flow in metastases-bearing livers after infusion of degradable starch microspheres. CIVALLERI, D., ROLLANDI, G., SIMONI, G., MALLARINI, G., REPETTO, M., and BONALUMI, U., Acta Chirurgia Scandinavica, 1985, 151, (7), 613–617.
  • The effect of elimination of macrophages on the tissue distribution of liposomes containing (3H)methotrexate. CLAASSEN, E., and VAN RooljEN, N., Biochimica et Biophysica Acta, 1984, 802, (3), 428–434.
  • Interaction of albumin and phospholipid : cholesterol liposomes in growth of Mycoplasma spp. CLI-as, R. G., and SOMERSON, N. L., Applied and Environmental Microbiology, 1986, 51, (2), 281–287.
  • Inhibition of serum complement haemolytic activity by lipid vesicles containing phosphatidylserine. COWS, A., and EASIERBROOK SMITH, S B., FEBS Letters, 1986, 197, (1-2), 321–327.
  • Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes. CONNOR, J., and HUANG, L., Journal of Cell Biology, 1985, 101, (2), 582–589.
  • Monoclonal antibody and liposomes. CONNOR, J., SULLIVAN, S., and HUANG, L., Pharmacology and Therapeutics, 1985, 28, (3), 341–365.
  • The fractional distribution of the cardiac output in man using microspheres labelled with technetium 99m. CREAN, P. A., PRATT, T., DAVIES, G. J., MYERS, M., LAVENDER, P., and MASER, A., British Journal of Radiology, 1986, 59, (699), 209–215.
  • Intracellular fate of liposome-encapsulated DNA in mouse liver. Analysis using electron microscope autoradiography and subcellular fractionation. CUDD, A., and NICOLAU, C., Biochimica et Biophysica Acta, 1985, 845, (3), 477–491.
  • Relation of liposomes to cell membranes. DEAMER, D. W., and USTER, P., Structure and Properties of Cell Membranes, CRC, Boca Raton, Fla, USA, 1985, pp. 103–122. Ed.: Benga, G.
  • Drugs and the Pharmaceutical Sciences, Vol. 20: Microencapsulation and Related Drug Processes. DEASY, P. B., Marcel Dekker, Inc., New York, N.Y. USA, 1984, 361p.
  • Divergent calciphoretic properties of negatively charged phospholipids in a two-phase system and in liposomes. DELEERS, M., and BRASSEUR, R., Research Communications in Chemical Pathology and Pharmacology, 1986, 51, (1), 65–72.
  • Immunization against experimental murine salmonellosis with liposome-associated 0-antigen. DESIDERIO, J. V., and CAMPBELL., S. G., Infection and Immunity, 1985, 48, (3), 658–663.
  • In vitro cytotoxic activity of cross-linked protein microcapsules. DESOIZE, B., JARDILLIER, J. C., KANOUN, K., GUERIN, D., and LEVY, M. C., Journal of Pharmacy and Pharmacology, 1986, 38, (1), 8–13
  • Aminoplast particles and microcapsules. DIETRICH, K., and NASTKE, R., Mitteilungsblatt-Chemische Gesellschaft in der Deutschen Demokratischen Republik, 1985, 32, (1), 11–16.
  • Effects of (dihydro)cytochalasin B, colchicine, monensin and trifluoperazine on uptake and processing of liposomes by Kupffer cells in culture. DIJKSTRA, J., VAN GALEN, M., and SCHERPHOF, G., Biochimica et Biophysica Acta, 1985, 845, (1), 34–42.
  • Biodegradable microcapsules. DOPPER, J. H., Natuur en Techniek, 1985, 53, (9), 698–703.
  • Poly(butyl 2-cyanoacrylate) nanoparticles with differing surface charges. DOUGLAS, S. J., ILLum, L., and DAVIS, S. S., Journal of Controlled Release, 1986,3, (1), 15–23.
  • Dissolution studies of microencapsulated 4-sulfonamidophenoxyacetic acid: effect of prepara-tive variables on dissolution. DRAGAN, D., AIRINEI, A., and CARPOV, A., Journal of Microencapsulation, 1985, 2, (3), 223–234.
  • Preparation of liposomes, using phase reversal technique excluding ultrasonic treatment. DVORKIN, V. M., Biokhimiya, 1985, 50, (5), 866–869.
  • Destabilization of phosphatidylethanolamine liposomes at the hexagonal phase transition temperature. ELLENS H., BENTZ, J., and SZOKA, F. C., Biochemistry, 1986, 25, (2), 285–294.
  • Isotopic light scattering of lipid vesicles. Water permeation and effect of alpha-tocopherol. ENGELBERT, H. P., and LAWACZECK, R., Chemistry and Physics of Lipids, 1985, 38, (4), 365–379.
  • Biological activity of liposome-encapsulated murine interferon gamma is mediated by a cell membrane receptor. EPPSTEIN D. A., MARSH, Y. V., VAN DER PAS, M. et al., Proceedings of the National Academy of Sciences, U.S.A., 1985, 82, (11), 3688–3692.
  • Liposome-delivered phosphatidylcholine enhances the acetylcholine sensitivity of dystrophic mouse myotubes. EUSEBI F., Cossu, G., MOLINARO, M., and GIACOMONI, D., Biochimica et Biophysica Acta, 1986, 855, (1), 197–199.
  • Phototherapy of tumors sensitized by liposome-bound porphyrins locally infiltered in neoplas-tic areas. FACCHINI V., CELA, M., GADDUCCI, A., et al., Medecine, Biologic, Environnement, 1984, 12,(1), 469–474.
  • Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules. FALLOUH N. A. K., ROBLOT TREUPEL, L., FESSI, H., DEVISSAGUET, J. P., and PUISIEUX, F., International Journal of Pharmaceutics, 1986, 28, (2-3), 125-132. 99m-technetium as a marker of liposomal deposition and clearance in the human lung. FARR, S. J., KELLAWAY, I. W., PARRY JONES, D. R., and WOOLFREY, S. G., International Journal of Pharmaceutics, 1985, 26, (3), 303–316.
  • Short-term fate of pulmonary delivered technetium-99m-labeled liposomes. FARR S. J., KELLAWAY, I. W., PARRY JONES, D. R., and WOOLFREY, S. G., 122nd British Pharmaceutical Conference, Leeds, England, Sept. 9–12. 1985. Journal of Pharmacy and Pharmacology, 1985, 37, (Suppl.), 61P.
  • The human erythrocyte ghost: A new experimental model for studying adenosine transport. FERNANDEZ RIVERA Rio, L., and GONZALEZ GARCIA, M. R., Archives of Biochemistry and Biophysics, 1985, 240, (1), 246–256.
  • The use of liposomes as carriers of multiple biological response modifiers for systemic activation of macrophages. FIDLER I. J., Int. Congr. Ser.-Excerpta Med., 1985, 690 (Ration. Biol. Response Modif. Cancer Treat.), 3–14.
  • The thermal properties of dilauryl phosphatidylethanolamine liposomes are affected by lipid source and preparation. FINEGOLD L., MELNICK, S. J., and SINGER, M. A., Chemistry and Physics of Lipids, 1985, 38,(4), 387–390.
  • Comparison of bone revascularization by musculocutaneous and cutaneous flaps using radioactive microsphere technique. FISHER J., and WOOD, M. B., Surgical Forum, 1985, 36, 554–556.
  • Distribution and fate of free and liposome-encapsulated (3H)normuramyl dipeptide and (3H)muramyl tripeptide phosphatidylethanolamine in mice. FOGLER W. E., WADE, R., BRUNDISH, D. E., and FIDLER, I. J., Journal of Immunology, 1985, 135,(2), 1372–1377.
  • Inductive-resonance energy transfer between chromophores localized within different parts of irradiated and nonirradiated erythrocyte ghosts. FOMENKO B. S., Di.imiivrovA, G. K., and Akouv, I. G., Radiohiologiya, 1985, 25, (1), 12–15.
  • Modulation of oxidant lung injury by using liposome-entrapped superoxide dismutase and catalase. FREEMAN B. A., TURRENS, J. F., MIRZA, Z. et al., Federation Proceedings, 1985, 44, (10), 2591–2595.
  • Influencing factors in the leakage of liposome and arabinoside cytosine (ARA-C) entrapped in liposomes in treatment of L1210 mouse leukemia. Fu N. W., Chung Hua Chung Liu Tsa Chih, 1985, 7, (4), 250–253.
  • Influence of the leakage of cytosine arabinoside (Ara-C) entrapped into liposomes in the treatment of L1210 mouse leukemia. Fu N., and ALLEN, T. M., Zhonghua Zhongliu Zazhi, 1985, 7, (4), 250–253.
  • Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil. jimoTo, S, N1iYkz WI, M., ENDOH, F et al., Cancer, 1985, 56, (10), 2404–2410.
  • Pharmacokinetics of ibuprofen microencapsulated granules. GAMBARO V., CAIAGARA, M., BENVENUTI, C., and SCARONI, C., Farmaco, Edizione Pratica, 1985, 40, (12), 407–414.
  • Liposome-encapsulated muramyltripeptide and ribavirin in the treatment of viral pneumonitis. GANGEM I, J. D., BARNHART, D., KRECII, L., JAN, P., and NACHTIGAL, M., International Symposium on Natural Immunity and Biological Response: Modification for the Therapy of Cancer and Other Diseases, I lonolulu, I Iawaii, U.S.A., Nov. 10-12, 1985, Nat. Immun. Cell Growth Regulation, 1985, 4, (5), 248.
  • Microencapsulation of Astiban acid for the treatment of Schistosomiasis mansoni. GOPALRATNAM, P. C., MASON, N. S., and SPARKS, R. E., Applied Biochemistry and Biotechnology, 1984, 10, 213–220.
  • Effect of magnesium stearate in preparation of Eudragit RS-microcapsules containing drugs. GoTo, S., KAWATA, M., NAKAMURA, M., and AOYAMA, T., Yakugaku Zasshi, 1985, 105, (11), 1087–1095.
  • Preparation and biopharmaceutical evaluation of gelatin microcapsules of piretanide. GoTo S., TSUJIY.ANIA,KAWATA, M., and SUZUKI, N., Journal of Controlled Release, 1985, 1, (4), 291–300.
  • Preparation and biopharmaceutical evaluation of microcapsules of ampicillin. GoTo S., 1 'ilium, T., and AOYAMA, T., Journal of Pharmacobiodynamics, 1985, 8, (4), 270–277.
  • Targeting of liposomes to accessible cells in vivo. GRFGoRiAnis, G SENIOR, J., WOLFF, B., and KIRBY, C., Annals of the New York Academy of Science, 1985, 446, 319–340.
  • The prevention of elastase-induced emphysema in hamsters by the intratracheal administr-ation of a synthetic elastase inhibitor bound to albumin microspheres. GUDAPATY S. R., LIENER, I. E., HOIDAL, J. R. et al., American Review of Respiratory Disease, 1985, 132, (1), 159–163.
  • Modification of the lipid composition of neuroblastoma C1300 cells using liposomes. GULAIA N. M., VOI.KOV, G. L., GOVSEEVA, N. N., and ARTEMENKO, I. P., Ukrains' kyi Biokhimichnyi Zhurnal, 1986, 58, (1), 39–43.
  • Enhancement of therapeutic effect of cyclophosphamide entrapped in liposomes in Walker 256 muscle tumor of rats. GUPTA H. P., SINGH, N. B., MATHUR, I. S., GUPTA, S. K., AKHLAQ, M., and AHMAD, A., Biological Membranes, 1985, 11, (2), 146–151.
  • Measurement of cerebral blood flow during xenon inhalation as measured by the micro-spheres method. GUR D., YONAS, H., JACKSON, D. L. et al., Stroke, 1985, 16, (5), 871–874.
  • Ocular therapy with nanoparticulate systems for controlled drug delivery. GURNY, R., BOYE, T., and IBRAHIM, H., Journal of Controlled Release, 1985, 2, 353–361.
  • Formulation and physical properties of polyurethane foam incorporating hollow micro-spheres. HAGARMAN J. A., CUNNION, J. P., and SANDS, B. W., Proc. SPI Annu. Tech./Mark. Conf., 1985, 29 (Magic Polyurethane), 161–163.
  • The effects of physical states of phospholipids on the incorporation and CB binding activity of human erythrocyte membrane proteins in reconstituted vesicles. HAH JONG SIK, State University, New York, Buffalo, NY, U.S.A., Dissertation, 1985, 195pp.
  • Transfer of oleic acid between albumin and phospholipid vesicles. I IAMILTON, .1. A., and CISTOLA, D. P., Proceedings of the National Academy of Sciences, U.S.A., 1986, 83, (1), 82–86.
  • Testicular blood flow in monkeys as measured by xenon clearance and radioactive micro-spheres. HARRISON R. M., LEWIS, R. W., and ROBERTS, J. A., Journal of Medical Primatology, 1985, 14, (1), 49–55.
  • Inhibition of cell proliferation and dihydrofolate reductase by liposomes containing metho-trexate-dimyristoylphosphatidylethanolamine derivatives and by the glycerophos-phorylethanolamine analogs. HASHIMOTO K., LOADER, J. E., KNIGHT, M. S., and KINSKY, S. C., Biochimica et Biophysica Acta, 1985, 816, (1), 169–178.
  • Drug targeting by using liposomes combined with monoclonal antibodies to cancer cells. HASHIMOTO, Y., Farumashia, 1985, 21, (12), 1213–1216.
  • An approach to cancer chemotherapy by application of monoclonal antibody-modified liposomes. HASHIMOTO Y., Int. Congr. Ser.-Excerpta Med, 1985, 690 (Ration. Biol. Response Modif. Cancer Treat.), 231–239.
  • Uptake enhancement of platinum in the dog kidney by microencapsulation of cisplatin and local injection. HECQUET B., DEPADT, G., FOURNIER, C., and MEYNADIER, J., Anticancer Research, 1986, 6, (1), 65–69.
  • Biodegradable polymers in controlled drug delivery. HELLER J., Critical Reviews in Therapeutic Drug Carrier Systems, 1984, 1, (1), 39–90.
  • Interaction of adriamycin with negatively charged model membranes: evidence of two types of binding sites. HENRY N., FANTINE, E. O., BOLARD, J., and GARNIER-SUILLEROT, A., Biochemistry, 1985,24, (25), 7085–7092.
  • Shape transformation of erythrocyte ghosts depends on ion concentrations. HERRMANN, A., MULLER, P., and GLASER, R., Bioscience Reports, 1985, 5, (5), 417–423.
  • Do new forms of administration optimise therapy? HESS H., Zeitschrift fur Augemeinmedizin, 1985, 61, (24), 842–846.
  • The evaluation of betaine as a liposome cryoprotective. HIGGINS J., HOGDES, N., 01.1.1FF, C., and PHILLIPS, A., 122nd British Pharmaceutical Conference, Leeds, England, Sept. 9–12. 1985. Journal of Pharmacy and Pharmacology, 1985,37, (Supp1,), 55P.
  • Lymphatic transport of liposome-encapsulated drugs following intraperitoneal adminis-tration. Effect of lipid composition. HIRANO K., H1 NT, C. A., STRUBBE, A., and MACGREGOR, R. D., Pharmaceutical Research, 1985, (6), 271–278
  • Mechanisms of topical delivery of liposomally entrapped drugs. Ho N. F. H., GANESAN, M. G., WEINER, N. D., and FI.YNN, G. L., Journal of Controlled Release, 1985,2, 61–65.
  • Ricinus comm unis agglutinin-mediated agglutination and fusion of glycolipid-containing phopholipid vesicles: effect of carbohydrate head group size, calcium ions, and spermine. HOEESTR D., and DUEZOITNES, N., Biochemistry, 1986, 25, (6), 1321–1330.
  • Fusion of liposomes induced by a cationic protein from the acrosome granule of abalone spermatozoa. HONG K., and VACQUIER, V. D., Biochemistry, 1986, 25, (3), 543–549.
  • Iron detoxification by haemoperfusion through deferoxamine-conjugated agarose-polyacro-lein microsphere beads. HOROM, ix, 1)., MARGI.1, S., and SHIMONI, T, Thomatertals, 1985, 6, (1), 9–16.
  • Microcell-mediated chromosome transfer from human tumor cells to human recipient cells evidenced by premature condensation of the transferred chromosomes. HOSARI E., BM DERI FIN, S., and GERHART, E., Cancer Genetics and Cytogenetics, 1986, 20, (1-2), 63–71.
  • Introduction of macromolecules into hemopoietic stem cells with an erythrocyte-ghost-mediated system. Hosoi T., OZAWA, K., TSAO, C. J. et al., Biochemical and Biophysical Research Communications, 1985, 128, (1), 193–198.
  • Separation of yeast protoplasts from membrane ghosts using an aqueous two-phase system. 1 losoNo, K., and I IAIIN, 11. B., Biochimica et Biophysica Acta, 1986, 855, (1), 189–192.
  • Dynamic transformation of liposomes. HOTANI H., Seitai no Kagaku, 1985, 36, (5), 523–530.
  • Transcatheter hepatic arterial embolization therapy with degradable poly(lactic acid) microspheres. ImmARA T., AKAGI, M., MORI, K., hat, S., SAKAMOTO, K., KATAUCHI, S., BEPPU, T., NOKANO, M., and TUNI, K., Gan to Kagaku Ryoho, 1985, 12, (10), 1944–1945.
  • Preparation of medicinal carbon and microcapsules containing acetylsalicylic acid on medicinal carbon. ISHIBASHI K., YAMADA, K., NODA, Y., and SIGASHIDE, F., Pharmaceutical Industry, 1985,47, (11), 1185–1189.
  • Liposome uptake by cultured macrophages mediated by modified low-density lipoproteins. IVANOV, V.0., PREOBRAZHENSKY, S. N., TSIBULSKY, V. P. et al., Biochimica et Biophysica Acta, 1985, 846, (1), 76–84.
  • Preparation of proteoliposomes-artificial substrate for evaluation of lecithin-cholesterol acyltransferase reaction in blood plasma. IVANOVA E. M., NIKIFOROVA, A. A., and ALKSNIS, E. G., Voprosy Meditsinskoi Khimii, 1985,31, (6), 123–126.
  • Liposomes as carriers of iodolipid radiocontrast agents for CT scanning of the liver. JENDRASIAK, G. L., FREY, G. D., and HELM, R. C., in, Investigative Radiology, 1985, 20, (9), 995–1002.
  • Early events in the selective cytotoxicity to tumor cells induced by liposomes containing plant phosphatidylinositol. JETT M., and ALVING, C. R., Inositol Phosphoinositides, Chilton Conf, 3rd, 1985, Humana, Clifton, NJ, U.S.A., pp. 91–97. Eds: Bleasdale, J. E., Eichberg, J. and Hauser, G.
  • Effects of bilayer fluidity on the binding of insulin to its receptor in rat adipocytes plasma membranes and liposomes. JONES M. N., MORE, J. E., and RILEY, D. J., 613th Meeting of the Biochemical Society, Cardiff, Wales, Mar. 20–22. 1985. Biochemical Society Transactions, 1985, 13, (6), 1130–1132.
  • Selective toxicity and enhanced therapeutic index of liposomal polyene antibiotics in systemic fungal infections. aJuLiAN°, R. L., LOPEZ BERESTEIN, G., HOFFER, R. et al., Annals of the New York Academy of Science, 1985, 446, 390–402.
  • Ibuprofen microcapsules from stearic acid. Part 1: Effect of particle size. KAGADIS, C. A., and CHoums, N. H., Pharmazie, 1985, 40, (11), 807–808.
  • Antiglycolipid antibodies in normal and pathologic human sera and synovial fluids. RAISE, S., YASUDA, T., KASUKAWA, R. et al., Vox Sanguinis, 1985, 49, (4), 292–300.
  • Production of gelatin microcapsules with the use of the emulsion-induction technique. KASER LIARD, B., Pharmaceutica Acta Helvetiae, 1985, 60, (12), 326–333.
  • Liposome-type artificial red blood cells stabilized with carboxymethyl chitin. KATO A., TANAKA, I., ARAKAWA, M., and KONDO, T., Biomaterials, Medical Devices and Artificial Organs, 1985, 13, (1-2), 61–82.
  • Effects of altering the ATP/ADP ratio on pump-mediated sodium potassium and sodium/ sodium exchanges in resealed human red blood cell ghosts. KENNEDY B. G., LUNN, G., and HOFFMAN, J. F., Journal of General Physiology, 1986, 87, (1), 47–72.
  • Characteristics of viable Brevibacterium linens cells, methionine and cysteine in milkfat-coated microcapsules. KIM S. C., and OLSON, N. F., Journal of Microencapsulation, 1985, 2, (3), 197–206.
  • Effect of liposomes sensitized with methotrexate-gamma-dimyristoylphosphatidylethanol-amine on cells that are resistant to methotrexate. KINSEY S. C., HASHIMOTO, K., LOADER, J. E., KNIGHT, M. S., and FERNANDES, D. J., Biochimica et Biophysica Acta, 1986, 885, (2), 129–135.
  • Fluorescein and microsphere distribution in ischemic skin and bowel. KLEIN S. G., HANSELL, J. R., BROUSSEAU, D. A., and SILVERMAN, D. G., Surgical Forum, 1985, 36, 542–544.
  • Intracellular activation of human and rodent macrophages by human lymphokines encap-sulated in liposomes. KLEINERMAN E. S., FOGI.ER, W. E., and FIDI.ER, 1. J., Journal of Leukocyte Biology, 1985, 37, (5), 571–584.
  • The potential use of liposome-mediated antiviral therapy. KOFF W. C., and FIDLER, I. J., Antiviral Research, 1985, 5, (3), 179–190.
  • Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon. KOFF W. C., FOGLER, W. E., GUTTERMAN, J., and FIDLER, I. J., Cancer Immunology and Immunotherapy, 1985, 19, (2), 85–89.
  • Interleukin-1 release by liposome-encapsulated macrophage activators. KOFF W. C., CERNY, E. H., REEVES, M. W., and LACHMAN, L. B., Progress in Leukocyte Biology, 1985, 2 (Physiol., Metab., Immunol. Actions Interleukin-1), 309–317.
  • Dry aerosol of monodisperse millimicrospheres for ventilation imaging: Production, delivery system, and clinical results in comparison with 81m-krypton and 127-xenon. KoHN H., KLECH, H., ANGELBERGER, P. et al., European Journal of Nuclear Medicine, 1985, 10, (9-10), 411–416.
  • Surface modification by microencapsulation. Kotsm, M., Kogyo Zairyo, 1985, 33, (12), 55–59.
  • Preparation and evaluation in vitro and in vivo of polycarbonate microspheres containing dibucaine. KOJIMA T., NAKANO, M., JUNI, K., IxouE, S., and YOSHIDA, Y., Chemical and Pharmaceutical Bulletin, 1985, 33, (11), 5119–5125.
  • Studies on the interaction of steroid substrates with adrenal microsomal cytochrome P-450 (P-450C21) in liposome membranes. KOMINAMI S., ITOH, Y., and TAKEMORI, S., Journal of Biological Chemistry, 1986, 261, (5), 2077–2083.
  • Liposomes-Mycobacteria incubation systems as a partial model of host-parasite interaction at cell membrane level. KONDO E., Suzuxi, K., KANAI, K., and YASUDA, T., Japanese Journal of Medical Science and Biology, 1985, 38, (4), 169–180.
  • Targeting of liposomes containing methotrexate towards Tetrahymena pyriforrnis cells. KOTSIFAKI, H., KAPOULAS, V., and DELICONSTANTINOS, G., General Pharmacology, 1985, 16, (6), 573–577.
  • Erythrocyte ghost drug delivery carriers: properties and pharmacological efficacy in treating cancer. KRUSE C. A., and FREEHAUF, C. L., International Symposium on Natural Immunity and Biological Response: Modification for the Therapy of Cancer and Other Diseases, Honolulu, Hawaii, U.S.A., Nov. 10–12. 1985. Nat. Immun. Cell Growth Regulation, 1985, 4, (5), 257–258.
  • Analytical procedures for microencapsulated trichloroethylene in rodent feed. KUHN G. O., Dux, T. P., RIDLEN, R. L., and STELTING, K. M., 190th American Chemical Society National Meeting, Chicago, Ill., U.S.A., Sept. 8–13. 1985. Abstracts of Papers-American Chemical Society, 1985, 190, no pagination.
  • Incorporation of the protective antigen of Brucella abortus into liposomes and the immuno-genic properties of the antigen-containing liposomes. KULIKOV V. I., KASHKIN, K. P., and DRANOVSKAIA, E. A., Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii, 1985, (12), 69–72.
  • Vesicle from rat cell ghosts and increased association of cell membrane proteins with cytoskeletons induced by cadmium. KUNIMOTO M., and MIURA, T., Biochimica et Biophysica Acta, 1985, 816, (I), 37–45.
  • Acrylic microspheres in vivo. X. Elimination of circulating cells by active targeting using specific monoclonal antibodies bound to microparticles. LAAKSO T., ANDERSSON, J., ARTURSSON, P., EDMAN, P., and SJOHOLM, I., Life Sciences, 1986,38, (2), 183–190.
  • Incorporation of ubiquinones into lipid vesicles and inhibition of lipid peroxidation. LAND, L., CABRINI, L., TADOLINI, B., SECHI, A. M., and PASQUALI, P., Italian Journal of Biochemistry, 1985, 34, (5), 356–363.
  • Endocytosis of MHC molecules evaluated by specifically targeted liposomes. LESERMAN L. D., MACHY, P., TRUNEH, A., and ZUNIGA, M. C., Cell Biol. Major Histocompat. Complex (Proc. Meet. P S Biomed. Sci. Symp.), 9th, 1984, Academic, Orlando, Fla, U.S.A., publ. 1985, pp. 185–193. Eds: Pernis, B. and Vogel, H. J.
  • Micropolarities of lipid bilayers and micelles. 3. Effect of monovalent ions on the dielectric constant of the water-membrane interface of unilamellar phosphatidylcholine vesicles. LESSARD J. G., and FRAGATA, M., Journal of Physical Chemistry, 1986, 90, (5), 811–817.
  • Use of vibrational spectroscopy in defining the role of clathrin in coated vesicle formation. LEVIN, I. W., VINCENT, J. S., BLUMENTHAL, R., and STEER, C. J., Biophysics Journal, 1986, 49, (1), 111–113.
  • Controlled binding of liposomes to cultured cells by means of lectins. LIAUTARD J. P., VIDAL, M., and PHILIPOTT, J. R., Cell Biology International Reports, 1985,9, (12), 1123–1137.
  • Electrical properties of aqueous dispersions of polymer microspheres. Lim K. H., and FRANSES, E. I., Journal of Colloid and Interface Science, 1986, 110, (1), 201–211.
  • Studies on microencapsulation. HI. Influence of coacervation-inducing agents and cooling rates on the preparation and in vitro release of bleomycin hydrochloride microcapsules. LIN, S. Y., Journal of Microencapsulation, 1985, 2, (2), 91–101.
  • Liposome-entrapped enzyme mediated immunoassays. LITCHFIELD W. J., and FREYTAG, J. W Enzyme-Mediated Immunoassay, Plenum, New York, NY, U.S.A., 1985, pp. 145–153. Eds: Ngo, T. T. and Lenhoff, H. M.
  • Prospects for liposomes as a novel drug delivery system. LOPEZ BERESTEIN, G., Cancer Bulletin, 1985, 37, (4), 203–206.
  • Temporary ischaemia of a large bowel segment induced by degradable starch microspheres in man. LOTE K., LEKVEN, J., HALVORSEN, J. F., et al., Acta Radiologica, Series Oncology, 1985, 24, (5), 395–399.
  • Patch-clamp measurement of the electrical breakdown of liposomes formed from plasma membrane lipids isolated from acclimated and nonacclimated rye secale-cereale cultivar puma leaves. LOVELACE R. V. E., HESTER, P. B., and STEPONKUS, P. L., 22nd Annual Meeting of the Society for Cryobiology, Madison, Wisconsin, U.S.A., June 18–21. 1985. Cryobiology, 1985, 22, (6), 626.
  • The formulation of polymethylcyanoacrylate nanoparticles as potential devices for drug targeting. LOWE R. A., GUPTA, P. K., HUNG, C. T., and PERRIER, D. G., Proceedings of the University of Otago Medical School, 1985, 63, (3), 67–68.
  • Frequency and temperature dependence of the relaxation times of liquid helium-3 confined by fluorocarbon microspheres. MAEGAWA S., SMUT-IL, A., MEISEL, M. W., and CHAPELLIER, M., Europhystcs Letters, 1986, 1, (2), 83–89.
  • Experimental study on the treatment of metastatic lymph nodes with local hyperthermia and temperature-sensitive liposomes containing bleomycin. MAEKAWA S., UEO, H., KAI, H., KITAMURA, M., and SUGIMACHI, K., Gan To Kagaku Ryoho, 1986, 13, (2), 271–274.
  • Sodium-potassium ATPase in artificial lipid vesicles: influence of lipid structure on pumping rate. MARCUS M. M., APELL, H. J., ROUDNA, M., SCHWENDENER, R. A., WEDER, H. G., and LAEUGER, P., Biochimica et Biophysica Acta, 1986, 854, (2), 270–278.
  • Albumin microspheres as delivery systems for photodynamic drugs: physico-chemical studies and their implications for in vivo situations. MARGALIT R., and SILBIGER, E., Journal of Microencapsulation, 1985, 2, (3), 183–196.
  • Synthesis of ATP catalyzed by the calcium magnesium ATPase from erythrocyte ghosts and cardiac sarcolemma effect of calmodulin. MAS OLIVA, J., ICSU (International Council of Scientific Unions) Short Reports, Vol. 3. Third European Bioenergetics Conference; Hannover, West Germany, Sept. 2–7. 1984, Cambridge University Press, Cambridge, U.K., publ. 1985, 745 p., pp. 412–413.
  • Evaluation of portal circulation in rats by rectal administration of 201T1 followed by intrasplenic injection of "Cr-labeled microspheres. MATSUMOTO S., FUKUDA, K., MORITA, S. et al., European Journal of Nuclear Medicine, 1985, 11,(8), 316–318.
  • High-performance liquid chromatographic determination of lipids in vesicles. MCCRACKEN, M. S., and MOLT, N. J., Journal of Chromatography, 1985, 348, (1), 221–227.
  • An inexpensive electrostatic charge neutralizer for microsphere nebulizer systems. MCCREADY, D. I., and PENDERGRASS, W. R. III., Journal of the Air Pollution Control Association, 1984, 34, (12), 1218–1219.
  • Extraction of a steroid transport system from Pseudomonas testosterone membranes and incorporation into synthetic liposomes. MCDONALD FRANCIS, M., KOWALSKY, N., and WATANABE, M., Journal of Steroid Biochemistry, 1985,23, (4), 523–528.
  • Nylon-encapsulated pharmaceuticals. MCGINITY J. W., and CUFF, G. W., Methods in Enzymology, 1985, 112, 84–101.
  • A potential application for the intracerebral injection of drugs entrapped within liposomes in the treatment of human cerebral gliomas. MCKERAN R. O., FIRTH, G., OLIVER, S., UTTLEY, D., and O'LAOIFtE, S., Journal of Neurology, Neurosurgery and Psychiatry, 1985, 48, (12), 1213–1219.
  • Update: microspheres. MCMURRER M., Plastics Compounding, 1985, 8, (7), 16, 21–24. 26, 28, 30–31.
  • The mode of action of polyacetylene and thiophene photosensitizers on liposome permeability to glucose. McRAE D. G., YAMAMOTO, E., and TOWERS, G. H. N., Biochimica et Biophysica Acta, 1985, 821, (3), 488–496.
  • Cholesterol synthesis in cultured human peripheral lymphocytes. Influence of LDL, HDL, cholesterol/phosphatidylcholine liposomes and complete serum. MELZNER I., HAMBITZER, R., and KIRKPATRICK, C. J., Biochimica et Biophysica Acta, 1986, 875, (3), 439–449.
  • Preliminary data on the encapsulation of biologically active materials in liposomes. MIHALACHE, O., BURDUCEA, O., OSSMAN, J., REPANOVICI, R., CONSTANTINESCU, N., MATEESCU, L., POPA, L. M., and CAJAL, N., Virologie, 1985, 36, (4), 279–284.
  • Systemic blood levels after intra-arterial administration of microencapsulated mitomycin C in cancer patients. MILANO G., BOUBLIL, J. L., BRUNETON, J. N., BOURRY, J., RENEE, N., THYSS, A., Roux, P., and NAMER, M., European Journal of Drug Metabolism and Pharmacokinetics, 1985, 10, (3), 197–201.
  • Use of lipid microspheres as a drug carrier for antitumor drugs. MIZUSHIMA Y., SHojt, Y., KAT0, T., FUKUSHIMA, M., and KUROZUMI, S., Journal of Pharmacy and Pharmacology, 1986, 38, (2), 132–134.
  • Transport of fatty acids across the membrane of human erythrocyte ghosts. MORAND, O., and AIDROT, M. S., Biochimica et Biophysica Acta, 1985, 835, (1), 68–76.
  • Preparation and evaluation of microencapsulated and coated ion-exchange resin beads containing theophylline. MOTYCKA S., NEWTH, C. J. L., and NAIRN, J. G., Journal of Pharmaceutical Sciences, 1985, 74, (6), 643–646.
  • The application of liposome technology to targeted delivery systems. MUFSON D., First Conference on the Latest Developments in Drug Delivery Systems, Philadelphia, PA, USA, Oct. 7–8. 1985. Pharmaceutical Technology, 1985, (Sp. Issue), 16–21.Ed: Robert, S.
  • Influence of the intracellular and extracellular cation concentration on monovalent cation efflux of resealed human erythrocyte ghosts. MULLER P., HERRMANN, A., BERNHARDT, I., and GLASER, R., Bioscience Reports, 1985, 5, (5), 425–432.
  • Enhancement of biodegradation of spilled oil in the sea by nutrients released from microcapsules. MURAKAMI A., OMI, S., KOZAWA, H., and YAMANE, A., Hakkokogaku Kaishi, 1985, 63, (2), 145–152.
  • Sterol orientations in phosphatidylcholine liposomes as determined by deuterium NMR. MURARI, R., MURARI, M. P., and BAUMANN, W. J., Biochemistry, 1986, 25, (5), 1062–1067.
  • Recent developments in drug carrier systems. NACUCCHIO M. C., GATTO, B. M. J., and D'AQutNo, M., Boletin de la Sociedad Quimica del Peru, 1985, 51, (1), 19–31.
  • The role of the maltodextrin-binding site in determining the transport properties of the lam-B protein. NAKAF, '1'., lsiiti, j., irid Futu:Nci, T, Journal of Biological Chemistry, 1986, 261, (2), 622–626.
  • Influence of preparative procedures on the membrane viscoelasticity of human red cell ghosts. NASH G. B., TRAN SON TAY, R., and MEISELMAN, H. J., Biochimica et Biophysica Ada, 1986, 855, (1), 105–114.
  • Utility of albumin microspheres for cancer chemotherapy. NATSUME, II., SUGIBAYASHI, K., and MORIMOTO, Y., Saishin Igaku, 1985, 40, (9), 1825–1830.
  • The systemic activation of macrophages by liposomes containing immunomodulators. NAVAR, R., and Fun.ga, 1. J.„S'pringer Seminars in Immunopathology, 1985, 8, (4), 413–428.
  • Peptide liposomes from amphiphilic amino acids. NEUMANN R., and RINGSDORF, H., Journal of the American Chemical Society, 1986, 108, (3), 487–490.
  • Fusion of influenza virus with cardiolipin liposomes at low pH: mass action analysis of kinetics and extent. NIR S., STFCMANN, T., and WILSCHUT, J., Biochemistry, 1986, 25, (1), 257–266.
  • Cellulose-walled microcapsules: 1. Effect of the solvent-nonsolvent proportions on the preparation of microcapsules from the system ethyl cellulose-chloroform-ethanediol. NIXON, J. R., and NIMMANNVI U., Journal of Microencapsulation, 1985,2, (2), 103–110.
  • The influence of crosslinking time on the adsorption characteristics of microcapsules containing activated charcoal prepared by gelatin-acacia coacervation. NORO S., Ism', F., and SAEGUSA, K., Chemical and Pharmaceutical Bulletin, 1985, 33, (11), 4649–4656.
  • Studies on liposomes from hydrogenated egg yolk lecithin. NUHN P., SCHENK, P., RICHTER, H., ARNDT, D., JANDRIG, J., and WINSEL, K., Pharmazie, 1985,40, (10), 705–709
  • In vitro and in vivo evaluation of cellacephate microcapsules of sodium salicylate prepared by pan coating. O'CONNELL, M. J. M., and DEASY, P. B., Journal of Microencapsulation, 1985, 2, (2), 111–121.
  • Liposomal phospholipid substitution and lung function in surfactant-depleted rats. 0131. AnEN,Klinische Paediatrie, 1985, 197, (2), 152–154.
  • Clearance of large amounts of natural surfactants and liposomes of dipalmitoylphosphatidyl-choline from the lungs of rabbits. OGuctu K., IKEGAMI, M., JACOBS, H., and JoBE, A., Experimental Lung Research, 1985,9, (3-4), 221–235.
  • Fate of lipid and encapsulated drug after intramuscular administration of liposomes prepared by the freeze-thawing method in rats. OHSAWA T., MATSUKAWA, Y TAKAKURA, Y., HAsunDA, M., and SEZAKI, H., Chemical and Pharmaceut-ical Bulletin, 1985, 33, (11), 5013–5022.
  • Studies on the effect of water-soluble additives and on the encapsulation mechanism in liposome preparation by the freeze-thawing method. 014SAWA, T., MIURA, H., and HARADA, K., Chemical and Pharmaceutical Bulletin, 1985, 33, (12), 5474–5483.
  • Core treatment for improving microencapsulability in simple gelatin coacervation method. OKADA, J., KI.SAI, A., and UEDA, S., Journal of Microencapsulation, 1985, 2, (3), 175–182.
  • Factors affecting microencapsulability in simple gelatin coacervation method. OKADA, J., KUSAI, A., and UEDA, S., Journal of Microencapsulation, 1985, 2, (3), 163–173.
  • Thermoselective permeation from a polymer-grafted capsule membrane. OKAHATA, Y., Nocucm, H., and SEKI, T., Macromolecules, 1986, 19, (2), 493–494.
  • Studies on suspension and emulsion. LXXXIV. Immobilization of trypsin onto microspheres of styrene-glycidyl methacrylate copolymer and its carboxylated derivative. OKuso M., Aoxr, Y., Mom, K., KAMEI, S., and MATSUMOTO, T., Kobunshi Ronbunshu, 1985, 42, (11), 829–833.
  • Sizing and separation of liposomes, biological vesicles, and viruses by high-performance liquid chromatography. OLLIVON M., WALTER, A., and BLUMENTHAL, R., Analytical Biochemistry, 1986, 152, (2), 262–274.
  • Microinjection of macromolecules into leukemic cells by cell fusion technique: Search for intracellular growth-suppressive factors. OZAWA K., Hosol, T., TsAo, C. J. et al., Biochemical and Biophysical Research Communications, 1985, 130, (1), 257–263.
  • New methodology for liposome targeting to specific cells. PAPAHADJOPOULOS D., HEATH, T., BRAGMAN, K., and MATTHAY, K., Annals of the New York Academy of Science, 1985, 446, 341–348.
  • Studies on the alpha-lactalbumin binding to phospholipid vesicles. PARK, B., and Km, H., Han'guk Saenghwa Hakhoechi, 1985, 18, (4), 393–402.
  • A critical evaluation of various procedures used to reconstitute chloroplast ATP synthetase into liposomes. PATERNOSTRE M., GALMICHK, J. M., GIRAULT, G., and RIGAUD, J. L., ICSU (International Council of Scientific Unions) Short Reports, Vol. 3. Third European Bioenergetics Conference; Hannover, West Germany, Sept. 2–7. 1984. Cambridge University Press, Cambridge, England, publ. 1985, 745 p., pp. 348–349. Ed: Schaeffer, G.
  • Study of rosin glycerol esters as microencapsulating materials. PATHAK Y. V., and DORLE, A. K., Journal of Microencapsulation, 1985, 2, (2), 137–140.
  • Preparation and pharmacology of polyphase liposomes of homoharringtonine (139-5). PEI GANG, MA ZHUQING, XIN SHUNMEI, PEI SUNLIN, and GU XUEQIU, Shenyang Yaoxueyuan Xuebao, 1985, 2, (4), 255–258.
  • Distribution of radiolabeled multilamellar liposomes injected intralymphatically and subcutaneously. PEREZ SOLER, R., LOPEZ BERESTEIN, G., JAHNS, M., WRIGHT, K., and KASI, L. P., International Journal of Nuclear Medicine and Biology, 1985, 12, (4), 261–266.
  • Ultrastructural characterization and fate of dertil-entrapped liposomes after intraperitoneal application in Fasciola hepatica infested rats. POLYAKOVA KRUSTEVA, O., GUBEV, E. E., and SVILENOV, D., Comptes Rendus de l' Academie Bulgare des Sciences, 1985, 38, (4), 497–500.
  • Changes in membrane liquid composition of human erythrocytes after dietary supplemen-tation of N-3 polyunsaturated fatty-acids maintenance of membrane fluidity. POP SNIJDERS, C., SCIIOUTEN, J. A., and VAN BLITTERSWIJK, W. J., and VAN DER VEEN, E. A., Biochirnica et Biophysica Acta, 1986, 854, (1), 31–37.
  • Microencapsulation technology for large-scale antibody production. PosiLLIco, E. G., Bio- Technology, 1986, 4, (2), 114–117.
  • Optimization of conditions for labeling albumin microspheres with technetium-99m when using tin(II) as a reductant. PRZYBOROWSKI M., and ORZECHOWSKI, A., Biuletyn Informacyjny Instytutu, Lekow, 1984, 31, (3), 319–327.
  • Pharmacological, toxicological and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes. RAHMAN A., WHITE, G., MORE, N., and SCHEIN, P. S., Cancer Research, 1985, 45, (2), 796–803.
  • Kinetics of proton exchange of phosphatidylethanolamine in phospholipid vesicles. RALPH, E. K., LANGE, Y., and REDFIELD, A. G., Biophysics Journal, 1985, 48, (6), 1053–1057.
  • Influence of vesicle size on complement-dependent immune damage to liposomes. RICHARDS, R. L., HABBERSETT, R. C., SCHER, I., JANOFF, A. S., SCHIEREN, H. P., MAYER, L. D., CULLIS, P. R., and ALvirsiu, C. R., Biochimica et Biophysica Acta, 1986, 855, (2), 223–230.
  • Uptake of liposomes lipid-vesicles by isolated Cassava manihotesculenta protoplasts for plant virus study. ROACH P., and GARNETT, H., 23rd Congress of the South African Society for Plant Pathology, Alice, Ciskei, South Africa, Jan. 22–24. 1985. Phytophylactica, 1985, 17, (1), 59.
  • Preparation of liposomes carrying lymphocyte membrane proteins. ROBINSON, P. J., Immunological Methods, 1985, 3, 125–132.
  • Cochlear blood flow in the rat. A comparison of 10- and 15-p spheres. RODGERS G. K., PRAZMA, J., and PILLSBURY, H. C., Archives of Otolaryngology, Head and Neck Surgery, 1986, 112, (2), 180–185.
  • Transfer of DNA across membranes: A model system using liposomes bearing bacteriophage lambda receptor protein. ROESSNER C. A., STRUCK, D. K., and IHLER, G. M., Biotechniques, 1984, 2, (3), 140–146.
  • Formation of transmembrane channels in liposomes during injection of lambda DNA. ROESSNER, C. A., and TIlLER, G. M., Journal of Biological Chemistry, 1986, 261, (1), 386–390.
  • Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules. ROGER M., CHAUSSAIN, J. L., BERLIER, P. BOST, M., CANLORBE, P., COLLE, M., FRANCOIS, R., GARANDEAU, P., LAHLOU, N., MOREL, Y. et at., Journal of Clinical Endocrinology and Metabolism, 1986,62, (4), 670–677.
  • Harmonic phase conjugation in liquid suspensions of microparticles via higher-order gratings. ROGOVIN D., McGRAw, R., and YEH, P., Physical Review Letters, 1985, 55, (26), 2864–2867.
  • Morphological properties of proteoliposomes reconstituted with the sodium pump methylmalonyl-CoA decarboxylase from Veillonella alcalescens. ROHDE M., DAEKENA, P., MAYER, F., and DIMROTH, P., FEBS Letters, 1986, 195, (1-2), 280–284.
  • Lysis of natural-killer-sensitive and resistant target cells by treatment with liposome-encapsulated natural killer cytotoxic factors. ROOZEMOND R., GRAVES, S., WRIGHT, S., and BONAVIDA, B., International Symposium on Natural Immunity and Biological Response: Modification for the Therapy of Cancer and Other Diseases, Honolulu, Hawaii, U.S.A., Nov. 10–12. 1985. Natural Immunity and Cell Growth Regulation, 1985,4, (5), 274.
  • Effects of liposome treatment and cytoskeleton-inhibiting drugs on the capping kinetics of rabbit T lymphocytes at various stages of differentiation. ROOZEMOND R. C., and Roilam, P. J. M., European Journal of Cell Biology, 1984, 35, (2), 322–326.
  • Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes. RUBAS W., SUPERSAXO, A., WEDER, H. G., HARTMANN, H. R., HENGARTNER, H., SCHOTT, H., and SCHWENDENER, R., International Journal of Cancer, 1986, 37, (1), 149–154.
  • Structural changes in the liposomes and the lamellar packing of liposomal lipids exposed to glycerin. RUDENKO S. V., BELITSER, N. V., CHERNYSHOV, V. I., ANISHCHUK, M. G., and KOZLOVA, T. R., Tsitologiya i Genetika, 1985, 19, (6), 412–415.
  • Liposome-mediated DNA transfer in yeast. RUSSELL I., JONES, R. M., PANCHAL, C. J., WESTON, B. J., and STEWART, G. G., Developments in Industrial Microbiology, 1984, 25, 475–484.
  • The liposome. RUYSSCHAERT J. M., Chimie Nouvelle, 1985, 3, (11), 255–258.
  • Comparative studies between liposomes containing muramyl dipeptide and various immunomodulators on activation of mouse peritoneal macrophages and NK cells. SAKITA, M., KAGEYAMA, N., and MAjimA, S., Oncology, 1985, 42, (4), 259–264.
  • Some factors affecting the dissolution rate of microencapsulated potassium chloride in directly compressed tablets. SAKR A., and OYOLA, J. R., Pharmazeutische Industrie, 1986, 48, (1), 92–94.
  • Microencapsulated drugs. SAMEJIMA M., Kagaku to Kogyo (Osaka), 1985, 59, (11), 452–457.
  • Improved drug delivery. SANDERS H. J., Chemical and Engineering News, 1985, 63, (13), 30–48.
  • Controlled delivery of an LHRH analogue from biodegradable injectable microspheres. SANDERS, L. M., MeRAE, G. I., VITALE, K. M., and KELL, B. A., Journal of Controlled Release, 1985,2, 187–195.
  • Effect of captopril on Na-K ATPase and Mg ATPase activities of erythrocyte ghost membranes. SANTORO, F. M., and DE LA Riva, I. J., Pharmacological Research Communications, 1985, 17, (4), 323–330.
  • Formation of living propagating polymer radicals in microspheres and their use in the synthesis of block copolymers. SATO T., and OTSU, T., Advances in Polymer Science, 1985, 71 (Anal./React./Morphol.), 41–77.
  • The use of liposomes to study drug-membrane interactions. SAUNDERS R. M., and ALEXANDER, J. J., South African Medical Journal, 1986, 69, (2), 103–106.
  • Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: Investigation in the rat prostate cancer model. SCHALLY A. V., and REDDING, T. W., Proceedings of the National Academy of Sciences, U.S.A., 1985, 82, (8), 2498–2502.
  • Uptake and intracellular processing of targeted and nontargeted liposomes by rat Kupffer cells in vivo and in vitro. SCHERPHOF G. L., DuKsTaA, J., SPANJER, H. H., et al., Annals of the New York Academy of Science, 1985, 446, 368–384. ATP-synthesis by reconstituted CF-OF-1 liposomes. SCHMIDT G., and GRAEBER, P., ICSU (International Council of Scientific Unions) Short Reports, Vol. 3. Third European Bioenergetics Conference, Hannover, West Germany, Sept. 2–7. 1984, Cambridge University Press, Cambridge, England, publ. 1985, 745 p., pp. 364–365. Ed: Schaeffer, G.
  • Pancreatic enzyme replacement therapy: Comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis. ScHNEtDEs M. U., KNOLL RUZICKA, M. L., DOMSCHKE, S. et al., Hepato-Gastroenterology, 1985, 32, (2), 97–102.
  • Calcium buffer sites in intact bovine rod outer segments: Introduction to a novel optical probe to measure ionic permeabilities in suspensions of small particles. SCHNETKAMP, P. P. M., Journal of Membrane Biology, 1985, 88, (3), 249–262.
  • Crystallized carbohydrate spheres for slow release and targeting. SCHRODER, U., Methods in Enzymology, 1985, 112, 116–128.
  • Proton pumping by bacteriorhodopsin reconstituted in large liposomes studied using the pH sensitive fluorescence probe pyranine. SEIGNEURET M., and RIGAUD, J. L., ICSU (International Council of Scientific Unions) Short Reports, Vol. 3. Third European Bioenergetics Conference; Hannover, West Germany, Sept. 2–7. 1984, Cambridge University Press, Cambridge, England, publ. 1985, 745 p., pp. 668–669. Ed: Shaeffer, G.
  • Liposomes as carriers of carbon-14-labelled penicillin and iodine-125-labelled albumin through the cell wall of Pseudomonas aeruginosa. SEKERI PATARYAS, K. H., VAKIRTZI LEMONIAS, C., PATARYAS, H. A., and LEGAKIS, J. N., International Journal of Biological Macromolecules, 1985, 7, (6), 379–381.
  • Regional myocardial and organ blood flow after myocardial infarction: application of the microsphere principle in man. SELWYN A. P., SHEA, M. J., FOALE, R., DEANFIELD, J. E., WILSON, R., DE LANDSHEERE, C. M., TURTON, D. L., BRADY, F., PIKE, V. W., and BROOKES, D. I., Circulation, 1986, 73, (3), 433–443.
  • Antibody-coated liposomes. The role of non-specific antibody adsorption. SENIOR, J., WATERS, J. A., and GREGORIADIS, G., FEBS Letters, 1986, 196, (1), 54–58.
  • Immune response mediated by liposome-associated protein antigens. IV. Modulation of antibody formation by vesicle-encapsulated methotresate. SHEK P. N., LOPEZ, N. G., and HEATH, T. D., Immunology, 1986, 57, (1), 153–157.
  • Physicochemical and immunological properties of albumin-associated dialkyl-ether phos-phatidylcholine liposomes. SHEK P. N., YUNG, B. Y., and STANACEV, N. Z., Biochimica et Biophysica Acta, 1986, 855, (1), 33–40.
  • Investigations on possibilities for microcapsulation of vitamin E acetate. SHEKERDZHIISKI R., TITEVA, S., MITIKOV, K., and MINKOV, E., Farmatsiya (Sofia), 1985, 35, (4), 23–28.
  • Determination of water permeability and its activation energy for giant paucilamellar egg lecithin liposomes. SHERBAN K., Tu, S. M., MELKERSON, M., and MCGRATH, J., 22nd Annual Meeting of the Society for Cryobiology, Madison, Wisconsin, U.S.A., June 18–21. 1985. Cryobiology, 1985, 22, (6), 628.
  • A novel method for encapsulation of macromolecules in liposomes. SHEW R. L., and DEAMER, D. W Biochimica et Biophysica Acta, 1985, 816, (1), 1–8.
  • Polymerization of amino acid under liposomal environment. SHIBATA A., YAMASHITA, S., ITO, Y., and YAMASHITA, T., Biochimica et Biophysica Acta, 1986, 854, (1), 147–150.
  • Complement-dependent immune damage to liposomes containing gangliosides. SHicHijo S., TOFFANO, G., and ALVING, C. R., Journal of Immunological Methods, 1985, 85, (1), 53–63.
  • Phospholipid liposomes enhance the infectivity of purified simian virus 40 virions. SHIMURA, H., and KIMURA, G., Virology, 1985, 144, (1), 268–272.
  • Enhancement of anti-inflammatory effects of biphenylylacetic acid by its incorporation into lipid microspheres. SHOJI Y., MIZUSHIMA, Y., YANAGAWA, A., SHIBA, T., TAKE, H., Fuji, M., and AMINO, M., Journal of Pharmacy and Pharmacology, 1986, 38, (2), 118–121.
  • Electron microscopic studies on tissue distribution of lipid microspheres used as drug delivery carriers. SHOJI Y., MIZUSHIMA, Y., YANAGAWA, A., and YONAHA, T., Drugs Under Experimental and Clinical Research, 1985, 11, (9), 601–609.
  • Polymerized diacetylenic phosphatidylcholine vesicles: synthesis and characterization. SINGH, A., and SCHNUR, J. M., Polymer Preprints, American Chemical Society, Division of Polymer Chemistry, 1985, 26, (2), 184–185.
  • Membrane potentials in reconstituted cytochrome c oxidase proteoliposomes determined by butyltriphenyl phosphonium cation distribution. SINGH A. P., and NimoLLs, P., Archives of Biochemistry and Biophysics, 1986, 245, (2), 436–445.
  • Antibody-mediated targeting of liposomes to erythrocytes in whole blood. SINGHAL A., BALI, A., and GUPTA, C. M., Biochimica et Biophysica Acta, 1986, 880, (1), 72–77.
  • Gangliosides in early interactions between vesicular stomatitis virus and CER cells. SINIBALDI, L., GOLDONI, P., SEGANTI, L. et al., Microbiologica, 1985, 8, (4), 355–365.
  • In vitro-in vivo evaluation of bacampicillin hydrochloride from microcapsules of a water-insoluble and an acid-soluble polymer. SJOEQVIST R., NYQVIST, H., SJOEVALL, J., and WESTERLUND, D., Journal of Microencapsulation, 1985, 2, (2), 123–136
  • The comparative bioavailability of liquid, wax-matrix, and microencapsulated preparations of potassium chloride. SEM l'AEIS, V. A., ACCHIARDO, S. R., WOJCIECHOWSKI, N. J., CARTER, C. A., MELIKIAN, A. P., and CHRIA. N., Journal of Clinical Pharmacology, 1985, 25, (8), 619–621.
  • The use of microencapsulated carbon in the removal of aluminium in dialysis patients. SLATOPOLSKY, E., WEERTS, C., FINCH, J., LEE, W., WINDUS, D., and DELMEZ, J., Meeting of the American Society of Nephrology, New Orleans, LA, U.S.A., Dec. 15–18. 1985. Kidney International, 1986, 29, (1), 226.
  • Therapeutic implications of activation of human monocyte-macrophages to the tumoricidal state by liposomes containing biological response modifiers. SONE S., MUTSUURA, S., OGAWARA, M., UTSUGI, T., and TSUBURA, E., Int. Congr. Ser.-Excerpta Med., 1985, 690 (Ration. Biol. Response Modif. Cancer Treat.), 44–52.
  • Osmotic resistance of rat erythrocytes in hyperinsulinism and streptozotocin-diabetes as compared with cholesterol and sialic acid contents of erythrocyte ghosts. SOSIN D., KORDOWIAK, A., and SARNECKA KELLER, M., Hormone and Metabolic Research, 1984, 16, (Suppl. 1), 89–91.
  • The role of galactose-receptors in the in-vivo uptake of lactosylceramide-containing lipo-somes by hepatocytes and Kupffer cells. SPANJER H. H., MORSELT, H., and SCHERPHOF, G., 19th Meeting of the European Association for the Study of the Liver, Berne, Switzerland, Sept. 6–8. 1984. Journal of Hepatology, 1985, (Suppl. 1), S133.
  • The purified alpha subunits of Go and Gi from bovine brain require beta gamma for association with phospholipid vesicles. STERNWEIS P. C., Journal of Biological Chemistry, 1986, 261, (2), 631–637.
  • Attempts of preparation of liposomes containing procaine hydrochloride. Farmacja Polska, 1985, 41, (10), 587–591.
  • Transfer of mink genes into mouse cells by means of isolated lipid-encapsulated nuclei. SUKOYAN, M. A., BELYAEV, N. D., BUDKER, V. G., GRADOV, A. A., PACK, S. D., and SEROV, O. L., Molecular and General Genetics, 1985, 201, (3), 487–491.
  • Microencapsulation of living cells-a long-term delivery system. SUN A. M., and Sins, G. M., Journal of Controlled Release, 1985, 2, 137–141.
  • Targetable liposomes for drug delivery. SI NAMOTO, J., Earumashia, 1985, 21, (12), 1229–1235.
  • Encapsulation of hemoglobin in phospholipid liposomes: characterization and stability. SZEBENI, J., Di' IORIO, E. E., HAUSER, H., and WINTERHALTER, K. H., Biochemistry, 1985, 24, (12), 2827–2832.
  • Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes. TADAKUMA T., IKEWAKI, N., YASCDA, T. et al., Antimicrobial Agents and Chemotherapy, 1985, 28, (1), 28–32.
  • Use of liposomes (synthetic lipid vesicles) in immunology. TADAKUMA T., and YASUDA, R., Digestive Organ and Immunology, 1985, 15, 265–270.
  • Interaction of spermine with polyphosphoinositides-containing liposomes and myo-inositol 1,4,5-triphosphate. TADOLINI B., and VARANI, E., Biochemical and Biophysical Research Communications, 1986, 135, (1), 58–64.
  • Therapy of autochthonous skin cancers in mice with intravenously injected liposomes containing muramyltripeptide. TALMADGE J. E., LENZ, B. F., KLABANSKY, R., SIMON, R., RIGGS, C., Guo, S., OLDHAM, R. K., and FIDLER, I. J., Cancer Research, 1986, 46, (3), 1160–1163.
  • Effect of fatty acyl chain length of phosphatidylcholine on their transfer from liposomes to erythrocytes and transverse diffusion in the membranes inferred by TEMPO-phosphatidylcholine spin probes. TAMURA A., YOSHIKAWA, K., Flip', T., OHKI, K., NOZAWA, Y., and SUMIDA, Y Biochimica et Biophysica Acta, 1986, 855, (2), 250–256.
  • Calcium induced phase separations in phospholipid mixtures. TAMURA-LIS, W., REBER, E. J., CUNNINGHAM, B. A., COLLINS, J. M., and Lis, L. J., Chemistry and Physics of Lipids, 1986, 39, (1-2), 119–124.
  • Preparation and stability of liposome-associated harringtonine. TANG, L., and WENG, G., Yaoxue Xuebao, 1985, 20, (6), 463–469.
  • The incorporation and in vitro release of sodium cromoglycate from multilamellar and reverse-phase evaporation liposomes. TAYLOR K. M. G., TAYLOR, G., KELLAWAY, I. W., and STEVENS, J., 122nd British Pharmaceutical Conference, Leeds, England, Sept. 9–12. 1985. Journal of Pharmacy and Pharmacology, 1985, 37, (Suppl.), 53 p.
  • Vinblastine sulphate encapsulation in phospholipid vesicles and liposomes. TER MINASSIAN SARAGA, L., and ALBRECHT, G., International Journal of Pharmaceutics, 1985, 24, (2-3), 149–164.
  • Use of liposomes for protective immunisation in sheep against Echis carinatus snake venom. THEAKSTON, R. D. G., ZUMBUEHL, G., and NEW, R. R. C., Toxicon, 1985, 23, (6), 921–925.
  • Long-acting biodegradable steroid microcapsules for parenteral administration. TICE T. R., Polymer Preprints, American Chemical Society, Division of Polymer Chemistry, 1985, 26, (2), 198–199.
  • Preparation of injectable controlled-release microcapsules by a solvent-evaporation process. TICE, T. R., and GILLEY, R. M., Journal of Controlled Release, 1985, 2, 343–352.
  • Preparation of inorganic/polymeric composite microspheres by direct suspension polymerization. TolcuoKA K., SENNA, M., and KUNO, H., Journal of Materials Science, 1986, 21, (2), 493–496.
  • Passive and active vectoring with microparticles: Localisation and drug release. TOMLINSON, E., Journal of Controlled Release, 1985,2, 385–391.
  • Experimental-morphological studies of liposome effect in carbon tetrachloride poisoning. TRINUS, F. P., PISAREV, A. A., CHUBENKO, A. V., and STEFANOV, A. V., Byulleten Eksperimentarnoi Biologii i Meditsiny, 1985, 100, (12), 714–715.
  • Liposome-embedded iron-porphyrins as an artificial oxygen carrier. TSUCHIDA, E., Annals of the New York Academy of Science, 1985, 446, 429–442.
  • Radioprotection of the kidney with degradable microspheres. A pilot study in the dog with repeated irradiation. TumA R., FORSBERG, J. O., GRAFFMAN, S., JUNG, B., and LYNCH, P. R., Upsala Journal of Medical Sciences, 1985, 90, (3), 259–263.
  • Antimetastatic effect of a liposome-entrapped synthetic analog of muramyl dipeptide. UMANSKII, V. lu., STEFANOV, A. V., Los, G. V., ANDRONOVA, T. M., and BALITSKII, K. P., Doklady Akademii Nauk SSSR, 1986, 286, (2), 474–476.
  • Temperature dependence of dielectric relaxations in alpha-elastin coacervate: Evidence for a peptide librational mode. Unity D. W., HENZE, R., REDINGTON, P. et al., Biochemical and Biophysical Research Communications, 1985, 128, (2), 1000–1006.
  • Phase-structure transitions of the elastin polypentapeptide-water system within the frame-work of composition-temperature studies. URRY D. W., TRAPANE, T. L., and PRASAD, K. U., Thopolymers, 1985, 24, (12), 2345–2356.
  • Continuous fluorometric assay of calcium transport by liposomes with Quin-2 entrapped: effect of phospholipase Al and unsaturated long-chain fatty acids. UTSUMI K., NOBORI, K., TERADA, S., MIYAHARA, M., and UTSUMI, T., Cell Structure and Function, 1985, 10, (4), 339–348.
  • Functional characterization of bacteriorhodopsin and ATP synthase containing liposomes. VAN DER BEND, R. L., PETERSEN, J., BERDEN, J. A., and VAN DAM, K., ICSU (International Council of Scientific Unions) Short Reports, Vol. 3. Third European Bioenergetics Conference; Hannover, West Germany, Sept. 2–7. 1984. Cambridge University Press, Cambridge, England, publ. 1985, 745 p., pp. 272–273. Ed: Schaeffer, G.
  • Transmembrane lipid transport between neuroblastoma C1300 cells and lecithin-cholesterol liposomes. Voucov G. L., GOVSEEVA, N. N., GULAYA, N. M., and ARTEMENKO, I. P., Biological Membranes, 1986,3, (2), 185–190.
  • Relative contribution of different vascular beds to the pressor effects of alpha-adrenoreceptor agonists and vasopressin in pithed rats: radioactive microsphere determination. WALDRON, C. J., and HICKS, P. E., Journal of Autonomic Pharmacology, 1985, 5, (4), 333–338.
  • Liposomes as vectors for calcium ionophores. WEISSMAN G., Annals of the New York Academy of Science, 1985, 446, 385–389.
  • Liposomes for oral administration of drugs. WOODLEY J. F., CRC Critical Reviews in Therapeutic Drug Carrier Systems, 1985, 2, (1), 1–18.
  • Sol-gel method using carbon tetrachloride as drop-formation medium for producing large thorium dioxide-base microspheres. YAMAGISHI S., and TAKAHASHI, Y., Journal of Nuclear Science and Technology, 1985, 22, (12), 995–1000.
  • Liposomes as drug carriers in cancer therapy: Hyperthermia and pH sensitivity as modalities for targeting. YATVIN M. B., CREE, T. C., TEGMO LARSSON, 1. M., and GIPP, J. J., Strahlentherapie, 1984, 160, (12), 732–740.
  • Cytolytic activity of liposomes containing stearylamine. YOSHIHARA E., and NAKAE, T., Biochimica et Biophysica Acta, 1986, 854, (1), 93–101.
  • Effects of purified ginseng saponins on multilamellar liposomes. Yu B. S., Kim, A., CHUNG, H. H., YOSHIKAWA, W., AKUTSU, H., and KYOGOKU, Y., Chemico-Biological Interactions, 1985, 56, (2-3), 303–320.
  • Rat microsomes and cytosol immobilized by microencapsulation in artificial cells. YUAN, Z. Y., and CHANG, T. M. S., International Journal of Artificial Organs, 1986, 9, (1), 63–68.
  • Liposome-mediated augmentation of brain SOD and catalase inhibits CNS oxygen toxicity. YUSA, T., CRAPO, J. D., and FREEMAN, B. A., Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology, 1984, 57, (6), 1674–1681.
  • Are liposomes able to carry neurotransmitter amino-acids through cerebral cell membranes. ZANCHIN, G., PIZZOLATO, G., DAM, M., VILLACARA, A., MERLO, D., and BATTISTIN, L., 10th Meeting of the International Society for Neurochemistry, Riva del Garda, Italy, May 19–24. 1985. Journal of Neurochemistry, 1985, 44, (Suppl.), S160.
  • Drug forms with microencapsulated iron(II) sulfate. ZHELYAZKOVA, ZH., DILOV, P., CHAKAROV, R., and IsAEv, I., Problemi no Farmaciyata, 1985, 13, 49–55.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.